Compile Data Set for Download or QSAR
maximum 50k data
Found 326 with Last Name = 'gero' and Initial = 'tw'
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600258(CHEMBL5201543)
Affinity DataIC50:  0.100nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600282(CHEMBL5196360)
Affinity DataIC50:  0.100nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600274(CHEMBL5206902)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600259(CHEMBL5182553)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHistamine H1 receptor(Cavia porcellus (domestic guinea pig))
A.H. Robins

Curated by ChEMBL
LigandPNGBDBM50007538(8-(2-Azetidin-1-yl-ethyl)-3-chloro-6-methyl-7,8-di...)
Affinity DataIC50:  0.260nMAssay Description:Inhibition of [3H]-mepyramine binding to the histamine receptor in guinea pig cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156378(US9018381, 3 | US9248140, 3)
Affinity DataIC50: <0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600257(CHEMBL5191510)
Affinity DataIC50:  0.300nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM204937(US9248140, 21)
Affinity DataIC50:  0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM204936(US9248140, 20)
Affinity DataIC50:  0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156377(US9018381, 2 | US9248140, 2)
Affinity DataIC50:  0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50518965(CHEMBL4443062)
Affinity DataIC50:  0.300nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156401(US9018381, 24 | US9248140, 24)
Affinity DataIC50:  0.400nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156402(US9018381, 25 | US9248140, 25)
Affinity DataIC50:  0.400nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156403(US9018381, 26 | US9248140, 26)
Affinity DataIC50:  0.400nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156380(US9018381, 4 | US9248140, 4)
Affinity DataIC50:  0.5nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156403(US9018381, 26 | US9248140, 26)
Affinity DataIC50:  0.5nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM204937(US9248140, 21)
Affinity DataIC50:  0.5nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600281(CHEMBL5177272)
Affinity DataIC50:  0.600nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600279(CHEMBL5191674)
Affinity DataIC50:  0.600nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156399(US9018381, 22 | US9248140, 22)
Affinity DataIC50:  0.600nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156387(US9018381, 10 | US9248140, 10)
Affinity DataIC50:  0.700nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156380(US9018381, 4 | US9248140, 4)
Affinity DataIC50:  0.800nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156382(US9018381, 5 | US9248140, 5)
Affinity DataIC50:  0.800nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156393(US9018381, 16 | US9248140, 16)
Affinity DataIC50:  0.800nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600273(CHEMBL5172573)
Affinity DataIC50:  0.900nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600261(CHEMBL5198812)
Affinity DataIC50:  0.900nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156385(US9018381, 8 | US9248140, 8)
Affinity DataIC50:  0.900nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156386(US9018381, 9 | US9248140, 9)
Affinity DataIC50:  0.900nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600260(CHEMBL5177306)
Affinity DataIC50:  0.900nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156386(US9018381, 9 | US9248140, 9)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156407(US9018381, 30 | US9248140, 30)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156400(US9018381, 23 | US9248140, 23)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156383(US9018381, 6 | US9248140, 6)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156376(US9018381, 1 | US9248140, 1)
Affinity DataIC50: <1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156407(US9018381, 30 | US9248140, 30)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156400(US9018381, 23 | US9248140, 23)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156376(US9018381, 1 | US9248140, 1)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156377(US9018381, 2 | US9248140, 2)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156378(US9018381, 3 | US9248140, 3)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156382(US9018381, 5 | US9248140, 5)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156384(US9018381, 7 | US9248140, 7)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156385(US9018381, 8 | US9248140, 8)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156387(US9018381, 10 | US9248140, 10)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156392(US9018381, 15 | US9248140, 15)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156393(US9018381, 16 | US9248140, 16)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 17 | US9018381, 18 | US9248140, 18)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBcl-2-like protein 1 [1-209](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM204936(US9248140, 20)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600263(CHEMBL5202129)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600268(CHEMBL5197154)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dana-Farber Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50600283(CHEMBL5178571)
Affinity DataIC50:  1.40nMAssay Description:Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 326 total ) | Next | Last >>
Jump to: